IVZ Invesco Ltd.

Invesco ltd: Form 8.3 - Willis Towers Watson PLC

Invesco ltd: Form 8.3 - Willis Towers Watson PLC

                                          

Form 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

  1. KEY INFORMATION
Name of person dealing (Note 1)Invesco Ltd.
Company dealt inWillis Towers Watson plc
Class of relevant security to which the dealings being disclosed relate (Note 2)Ordinary Shares IE00BDB6Q211
Date of dealing18-01-2021
  1. INTERESTS AND SHORT POSITIONS
  1. Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
 LongShort
 Number (%)Number      (%)
(1) Relevant securities1,504,229        1.166%      2,900                 0.002%
(2) Derivatives (other than options)  
(3) Options and agreements to purchase/sell  
Total1,504,229        1.166%      2,900                   0.002%
       

 Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:LongShort
 No. (%)Number      (%)
(1) Relevant securities  
 



(2) Derivatives (other than options)
  
 



(3) Options and agreements to purchase/sell
  
Total  
       

                                     

  1. DEALINGS (Note 4)
  1. Purchases and sales
 



Purchase/sale
 



Number of relevant securities
 



Price per unit (Note 52
Purchase1,657206.65 USD
  1. Derivatives transactions (other than options transactions)
Product name,



e.g. CFD
Nature of transaction



(Note 6)
Number of relevant securities



(Note 7)
Price per unit



(Note 5)
    
  1. Options transactions in respect of existing relevant securities
  1. Writing, selling, purchasing or varying
Product name,

e.g. call option
Writing, selling, purchasing, varying etc.Number of securities to which the option relates (Note 7)Exercise priceType, e.g. American, European etc.Expiry dateOption money paid/received per unit (Note 5)
       
  1. Exercising
Product name,



e.g. call option
Number of securitiesExercise price per unit (Note 5)
   
  1. Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction



(Note 8)
DetailsPrice per unit



(if applicable) (Note 5)
   



  1. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives



Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)                                            NO

Date of disclosure19-01-2021
Contact nameSam Edwards
Telephone number
If a connected EFM, name of offeree/offeror with which connectedN/A
If a connected EFM, state nature of connection (Note 10) 


EN
19/01/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Invesco Ltd.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Invesco Ltd.: Semiannual Update

Our credit view of this issuer reflects its good liquidity and laddered debt tenors, offset by its integration of acquisitions and its leverage stemming from acquisitions.

Invesco Ltd: 1 director

A director at Invesco Ltd sold/sold after exercising options 232,413 shares at 17.430USD and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

 PRESS RELEASE

Invesco ltd: Form 8.3 - Horizon Therapeutics plc

Invesco ltd: Form 8.3 - Horizon Therapeutics plc FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVERRULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1.      KEY INFORMATION (a)   Full name of discloserInvesco Ltd.(b)   Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c)   Name of offeror/offeree in r...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch